A gene encoding an apurinic/apyrimidinic endonuclease-like protein is up-regulated in human gastric cancer

World Journal of Gastroenterology

Volumn 9, Issue 6, 2003, Pages 1196-1201

  Wang, Gang Shi ^a   Wang, Meng Wei ^a   Wu, Ben Yan ^a   Liu, Xiao Bing ^a   You, Wei Di ^a   Yang, Xin Yan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APURINIC APYRIMIDINIC ENDODEOXYRIBONUCLEASE LIKE PROTEIN; COMPLEMENTARY DNA; DIGOXIGENIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; AMINO ACID SEQUENCE; ARTICLE; BASE PAIRING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CODE; GENETIC DATABASE; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRECANCER; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE; SEQUENCE HOMOLOGY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH MUCOSA;

EID: 0038390995     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i6.1196     Document Type: Article

References (55)

1. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002; 100: 249-260
2. El-Rifai W, Powell SM. Molecular biology of gastric cancer. Semin Radiat Oncol 2002; 12: 128-140
3. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas. Cancer 1999; 85: 1894-1902
4. Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A. Status of c-erbB-2 in gastric adenocarcinoma: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immunosorbent assay. Int J Cancer 2002; 98: 833-837
5. Yoo J, Park SY, Robinson RA, Kang SJ, Ahn WS, Kang CS. Ras gene mutation and expression of ras signal transduction mediators in gastric adenocarcinomas. Arch Pathol Lab Med 2002; 126: 1096-1100
6. Chang MS, Kim HS, Kim CW, Kim YI, Lan Lee B, Kim WH. Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. Hum Pathol 2002; 33: 415-420
7. Gurel S, Dolar E, Yerci O, Samli B, Ozturk H, Nak SG, Gulten M, Memik F. Expression of p53 protein and prognosis in gastric carcinoma. J Int Med Res 1999; 27: 85-89
8. Liu XP, Tsushimi K, Tsushimi M, Kawauchi S, Oga A, Furuya T, Sasaki K. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: Its relationships with cell proliferation activity and prognosis. Cancer Lett 2001; 170: 183-189
9. Sato K, Tamura G, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Motoyama T. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Cancer 2001; 85: 199-203
10. Lee JH, Abraham SC, Kim HS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Rashid A, Hamilton SR, Wu TT. Inverse relationship between APC gene mutation in gastric adenomas and devevelopment of adenocarcinoma. Am J Pathol 2002; 161: 611-618
11. Zhou Y, Gao SS, Li YX, Fan ZM, Zhao X, Qi YJ, Wei JP, Zou JX, Liu G, Jiao LH, Bai YM, Wang LD. Tumor suppressor gene p16 and Rb expression in gastric cardiac precancerous lesions from subjects at a high incidence area in northern China. World J Gastroenterol 2002; 8: 423-425
12. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol 2002; 161: 399-403
13. Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ. Molecular studies into the role of CD44 variants in metastatis in gastric cancer. Mol Pathol 1999; 52: 25-28
14. Van Rees BP, Saukkonen K, Ristimaki A, Polkowski W, Tytgat GN, Drillenburg P, Offerhaus GJ. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196: 171-179
15. Kikuchi T, Itoh F, Toyota M, Suzuki H, Yamamoto H, Fujita M, Hosokawa M, Imai K. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. Int J Cancer 2002; 97: 272-277
16. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumour progression. Br J Cancer 2002; 86: 737-743
17. Yu J, Leung WK, Ebert MP, Ng EK, Go MY, Wang HB, Chung SC, Malfertheiner P, Sung JJ. Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 2002; 87: 91-97
18. Ebert MP, Gunther T, Hoffmann J, Yu J, Miehlke S, Schulz HU, Roessner A, Korc M, Malfertheiner P. Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 2000; 60: 1995-2001
19. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-124
20. Bai YQ, Yamamoto H, Akiyama Y, Tanaka H, Takizawa T, Koike M, Kenji Yagi O, Saitoh K, Takeshita K, Iwai T, Yuasa Y. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett 2002; 176: 47-55
21. Saitoh T, Mine T, Katoh M. Up-regulation of WNT8B mRNA in human gastric cancer. Int J Oncol 2002; 20: 343-348
22. Li Z, Wang Y, Song J, Kataoka H, Yoshii S, Gao C, Wang Y, Zhou J, Ota S, Tanaka M, Sugimura H. Genomic structure of the human beta-PIX gene and its alteration in gastric cancer. Cancer Lett 2002; 177: 203-208
23. Yoshikawa Y, Mukai H, Hino F, Asada K, Kato I. Isolation of two novel genes, down-regulated in gastric cancer. Jan J Cancer Res 2000; 91: 459-463
24. Wang G, Wang M, You W, Li H. Cloning and primary expression analyses of down-regulated cDNA fragment in human gastric cancer. Zhonghua Yixue Yichuanxue Zazhi 2001; 18: 43-47
25. Wang JH, Chen SS. Screening and identification of gastric adenocarcinoma metastasis-related genes by using cDNA microarray coupled to FDD-PCR. Shengwu Huaxue Yu Shengwu Wuli Xuebao (Shanghai) 2002; 34: 475-481
26. Wang X, Lan M, Shi YQ, Lu J, Zhong YX, Wu HP, Zai HH, Ding J, Wu KC, Pan BR, Jin JP, Fan DM. Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell. World J Gastroenterol 2002; 8: 54-59
27. Saitoh T, Mine T, Katoh M. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. Int J Oncol 2002; 20: 785-789
28. Line A, Stengrevics A, Slucka Z, Li G, Jankevics E, Rees RC. Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer 2002; 86: 1824-1830
29. Lee S, Baek M, Yang H, Bang YJ, Kim WH, Ha JH, Kim DK, Jeoung DI. Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays. Cancer Lett 2002; 184: 197-206
30. Liu LX, Liu ZH, Jiang HC, Qu X, Zhang WH, Wu LF, Zhu AL, Wang XQ, Wu M. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J Gastroenterol 2002; 8: 580-585
31. El-Rifai W, Smith MF Jr, Li G, Beckler A, Carl VS, Montgomery E, Knuutila S, Moskaluk CA, Frierson HF Jr, Powell SM. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res 2002; 62: 4061-4064
32. Wang GS, Wang MW, Wu BY, You WD. A lamin-like protein gene is down-regulated in human gastric cancer. Zhonghua Yixue Yichuanxue Zazhi 2003; 20 in press
33. Wang GS, Wang MW, Wu BY, You WD, Yang XY. A novel gene, GCRG224, is differentially expressed in human gastric mucosa. World J Gastroenterol 2003; 9: 30-34
34. Wang GS, Wang MW, You WD, Wang HF, Feng MF. Fluorescent mRNA differential display technique. Zhongguo Yingyong Shenglixue Zazhi 2000; 16: 373-376
35. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402
36. Komminoth P. Digoxigenin as an alternative probe labeling for in situ hybridization. Diagn Mol Pathol 1992; 1: 142-150
37. Komminoth P, Merk FB, Leav I, Wolfe HJ, Roth J. Comparison of 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Expression of mRNA of the seminal vesicle secretion protein II and androgen receptor genes in the rat prostate. Histochemistry 1992; 98: 217-228
38. Furano AV. The biological properties and evolutionary dynamics of mammalian LINE-1 retrotransposons. Prog Nucleic Acid Res Mol Biol 2000; 64: 255-294
39. Volff JN, Korting C, Froschauer A, Sweeney K, Schartl M. Non-LTR retrotransposons encoding a restriction enzyme-like endonuclease in vertebrates. J Mol Evol 2001; 52: 351-360
40. Fritz G. Human APE/Ref-1 protein. Int J Biochem Cell Biol 2000; 32: 925-929
41. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000; 461: 83-108
42. Wilson DM III, Barsky D. The major human abasic endonuclease: Formation, consequences and repair of abasic lesions in DNA. Mutat Res 2001; 485: 283-307
43. Meira LB, Devaraj S, Kisby GE, Burns DK, Daniel RL, Hammer RE, Grundy S, Jialal I, Friedber EC. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res 2001; 61: 5552-5557
44. Duguid JR, Eble JN, Wilson TM, Kelley MR. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme. Cancer Res 1995; 55: 6097-6102
45. Kakolyris S, Kaklamanis L, Engels K, Turley H, Hickson ID, Gatter KC, Harris AL. Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence. Cancer Res 1997; 57: 1794-1797
46. Kelley MR, Cheng L, Foster R, Tritt R, Jiang JZ, Broshears J, Koch M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001; 7: 824-830
47. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, Kelley MR. The apurinic/apyrimidinic endonucleases (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 1997; 17: 3713-3719
48. Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR. DNA repair-redox gene enzyme apurinic endonuclease in cervical cancer: Evaluation of redox control of HIF-1alpha and prognostic significance. Int J Oncol 2001; 19: 799-802
49. Herring CJ, West CM, Wilks DP, Davidson SE, Hunter RD, Berry P, Forster G, MacKinnon J, Rafferty JA, Elder RH, Hendry JH, Margison GP. Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer 1998; 78: 1128-1133
50. Moore DH, Michael H, Tritt R, Parsons SH, Kelly MR. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 2000; 6: 602-609
51. Kakolyris S, Kaklamanis L, Engels K, Fox SB, Taylor M, Hickson ID, Gatter KC, Harris AL. Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis. Br J Cancer 1998; 77: 1169-1173
52. Robertson KA, Bullock HA, Tritt R, Zimmerman E, Ulbright TM, Foster RS, Einhorn LH, Kelley MR. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001; 61: 2220-2225
53. Bobola MS, Blank A, Berger MS, Stevens BA, Silber JR. Apurinic/apyrimidinic endonuclease activity is elevated in human adult gliomas. Clin Cancer Res 2001; 7: 3510-3518
54. Russo D, Arturi F, Bulotta S, Pellizzari L, Filetti S, Manzini G, Damante G, Tell G. Ape1/Ref-1 expression and cellular localization in human thyroid carcinoma cell lines. J Endocrinol Invest 2001; 24: RC10-RC12
55. Koukourakis MI, Giatromanolaki A, Kakolyris S, Sivridis E, Georgoulias V, Funtzilas G, Joclspm ID, Gatter KC, Harris AL. Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome. Int J Radiat Oncol Biol Phys 2001; 50: 27-36